Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716

Alcohol and Alcoholism

Volumn 33, Issue 2, 1998, Pages 126-130

  Colombo, Giancarlo ^a   Agabio, Roberta ^a   Fà, Mauro ^a   Guano, Lorenza ^b   Lobina, Carla ^a   Loche, Antonella ^b   Reali, Roberta ^a   Gessa, Gian Luigi ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b GET Pharmaceutical Laboratory   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; RIMONABANT; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT;

EID: 0031926412     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.alcalc.a008368     Document Type: Article

References (14)

1. Arnone, M., Maruani, J., Chaperon, F., Thiéhot, M.-E., Poncelet, M., Soubrié, P. and Le Fur, G. (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132, 104-106.
2. Colombo, G. (1997) Ethanol drinking behaviour in Sardinian alcohol-preferring rats. Alcohol and Alcoholism 32, 443-453.
3. Crabbe, J. C. and Li, T.-K. (1995) Genetic strategies in preclinical substance abuse research. In Psychopharmacology: The Fourth Generation of Progress, Bloom, F. E. and Kupfer, D. J. eds. pp. 799-811. Raven Press, New York.
4. Eriksson, J. P. C. (1980) Problems and pitfalls in acetaldehyde determinations. Alcoholism: Clinical and Experimental Research 4, 22-29.
5. Fratta, W., Martellotta, M. C., Cossu, G., Fattore, L. and Gessa, G. L. (1997) Self-administration of the cannabinoid agonist WIN 55,212-2 in mice: interaction with opioid systems. Trends in Neuroscience 20 (Suppl. 9), 7.
6. 9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neuroscience Letters 226, 159-162.
7. Gessa, G. L., Melis, M., Muntoni, A. L. and Diana, M. (1997) Cannabinoids activate mesolimbic dopamine neurons by an action on CB1 receptors. European Journal of Pharmacology, 341, 39-44.
8. Koob, G. F. and Bloom, F. E. (1988) Cellular and molecular mechanisms of drus dependence. Science 242, 715-723.
9. Pério, A., Rinaldi-Carmona, M.. Maruani, J., Barth, F., Le Fur, G. and Soubrié, P. (1996) Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A. Behavioural Pharmacology 7, 65-71.
10. Pertwee, R. G. (1995) Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors: an overview. In Cannabinoid Receptors, Pertwee, R. G. ed., pp. 1-34. Academic Press, London.
11. Rinaldi-Carmona, M., Barth, F., Héauime, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., Ferrara, P., Soubrié, P., Breliére, J. C. and Le Fur, G. (1994) SR 141716A, a potent and selective antagonist of the cannabinoid receptor. FEBS Letters 350, 240-244.
12. 1 opioid receptor mechanism. Science 276, 2048-2050.
13. Wiley, J. L., Barrett, R. L., Lowe, J., Balster, R. L. and Martin, B. R. (1995a) Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34, 669-676.
14. 9-Tetrahydrocannabinol in rats and rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 275, 1-6.